Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan;135(1):29-38.
doi: 10.1007/s00432-008-0425-z. Epub 2008 Jun 4.

Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction

Markus Menges  1 , Thomas Hoehler
Affiliations
Review

Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction

Markus Menges et al. J Cancer Res Clin Oncol. 2009 Jan.

Abstract

Gastric cancer is a major health issue and a leading cause of death worldwide. The results of standard therapy remain unsatisfactory mainly because of diagnosis at the late stage of disease. Innovative strategies such as neoadjuvant chemotherapy in locally advanced cancer have improved the outcome even in operable cases. Whether an adjuvant radiochemotherapy is of benefit after curative resection including systematic lymphadenectomy remains yet unclear. Some progress has been made in the palliative setting by introducing new substances. This review examines recent advances in the systemic treatment of gastric and gastroesophageal junction cancer.

PubMed Disclaimer

References

    1. Al-Batran S, Hartmann J, Probst S et al (2008) Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 26:1435. doi:10.1200/JCO.2007.13.9378 - PubMed
    1. Ajani JA, Baker J, Pisters PW et al (2002) CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study. Cancer 94(3):641–646. doi:10.1002/cncr.10279 - PubMed
    1. Ajani JA, Lee FC, Singh DA et al (2006) Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma. J Clin Oncol 24:663–667. doi:10.1200/JCO.2005.04.2994 - PubMed
    1. Boigé V, Pignon J, Saint-Aubert B, et al 2007 Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE). J Clin Oncol, 25; 18s #4510
    1. Boku N, Yamamoto S, Shirao K et al (2007) Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912). J Clin Oncol 25:965S. doi:10.1200/JCO.2006.10.0131

MeSH terms